ClinicalTrials.gg
Not yet recruitingNCT06415552Updated Dec 6, 2024

Implementation of Online Mindfulness-Based Stress Reduction Tailored for People with Multiple Sclerosis

An interventional study of Mindfulness-Based Stress Reduction in Multiple Sclerosis, sponsored by Robert Simpson. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2024-12-06.

Sponsored by Robert Simpson · Not applicable, Interventional, and Health services research

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 257 studies in Multiple Sclerosis with a site in Canada — 25 open to participants now, 43 under way, 12 of them phase 3. Multiple Sclerosis · Canada.

Planned enrollment
134th of 215
120 · median 177
Started
2025
with 10 others
No phase
53 of 257
12 open now
Primary completion
2026-12
later than 21 of 42 live
Registered
243rd of 257
by date

Among the 257 studies in Multiple Sclerosis with a site in Canada, this one is the 134th largest by planned enrollment of the 215 interventional ones that give a count, is one of 11 that started in 2025, is one of 53 with no phase, reaches primary completion later than 21 of the 42 other live ones, and was the 243rd registered.

Multiple Sclerosis

3,273 studies on the registry are indexed under Multiple Sclerosis; 665 are open to participants now.

Browse Multiple Sclerosis studies →

Open to participants now

25 of the 257 studies in Multiple Sclerosis with a site in Canada are open now. Recruiting first, the newest first:

20 more — sign in →

All 25 open studies →

A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →

Who these studies take

Of the 434 Multiple Sclerosis studies recruiting now, 164 (38%) set no upper age limit and 214 (49%) stop at 75 or younger; 40 take children under 18; 95 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 257 studies in Multiple Sclerosis with a site in Canada, or all of them as a file.
02

Study summary

This project aims to implement and investigate a mindfulness-based stress reduction (MBSR) in people with multiple sclerosis (PwMS). The main objective is to implement MBSR intervention for PwMS in a major tertiary care clinic for PwMS. We will iteratively refine the intervention as required based on stakeholder feedback and any other emergent contextual findings.

Participants will be asked to take part in an 8-week MBSR course and report changes in anxiety, depression, quality of life, emotional regulation, self-compassion, mindfulness, and health services use.

03

Conditions studied

  • Multiple Sclerosis

Browse trials for

Keywords

  • Mindfulness
04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age >18 years \</= 60 years
  2. Diagnosis of MS or related condition (Clinically Isolated Syndrome, Neuromyelitis Optica Spectrum Disorder, Chronic Inflammatory Demyelinating Neuropathy)
  3. Able to understand spoken and written English
  4. Willing to take part in an MBSR course

Exclusion criteria

Exclusion Criteria:

  1. Cognitive impairment (\<26 on the )
  2. Severe active mental health impairment (psychosis, suicidality)
  3. Medical instability (terminal/life threatening inter-current illness)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Other
    Mindfulness-Based Stress Reduction

    8-week Mindfulness-Based Stress Reduction course

    Behavioral: Mindfulness-Based Stress Reduction

Interventions

  • BehavioralMindfulness-Based Stress Reduction

    Eight iterations of the MBSR course will be delivered, over a total period of 24 months. Each iteration will take place over 8 weeks. Courses would consist of 8 weekly sessions, led by certified mindfulness instructors. Sessions will include core meditation practices, psychoeducation, and home practices.

06

What researchers measure

Primary outcomes

  1. Recruitment

    The investigators will measure the number of participants eligible for and recruited to the study.

    Time frame: 24 months

  2. Retention

    The investigators will measure the percentage of participants who complete outcome data.

    Time frame: 24 months

  3. Adherence

    The investigators will measure the number of participants who completed the mindfulness-based stress reduction course.

    Time frame: 24 months

  4. Follow-up rates

    The investigators will measure the percentage of participants who complete outcome measures pre-intervention, post-intervention, and at 3 months post-intervention.

    Time frame: 24 months

Secondary outcomes

  1. Quality of Life using the Multiple Sclerosis Impact Scale (MSIS-29)

    Measured using the Multiple Sclerosis Impact Scale. Items on the scale have a Likert scale from 1-5, with a range of 0-100 total and higher scores indicating greater disability.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  2. Quality of Life using the EuroQol (EQ-5D-5L)

    Measured using the EQ-5D-5L. The total score ranges from 1-100, with higher values indicating better perceived health.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  3. Anxiety

    Measured using the Hospital Anxiety and Depression Scale. The total score ranges from 0-21, with higher values representing increased anxiety symptoms.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  4. Depression

    Measured using the Hospital Anxiety and Depression Scale. The total score ranges from 0-21, with higher values representing increased anxiety symptoms.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  5. Health services use

    Measured using the Client Services Receipt Inventory. This instrument is used to collect information on the use of health services.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  6. Emotion regulation

    Measured using the Difficulties in Emotion Regulation Scale - Short Form. Answers are assessed using a 5-point Likert scale. Higher values indicate greater difficulties in emotion regulation.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  7. Self-compassion

    Measured using the Self-Compassion Scale - Short Form. The total score ranges from a 1-5 Likert scale, with higher scores representing high self-compassion.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  8. Mindfulness

    Measured using the Five-facet Mindfulness Questionnaire. Answers are assessed using a 5-point Likert scale. Higher scores in each facet indicate higher levels of mindfulness.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  9. Climate

    Measured using the Group Climate Questionnaire-Engage Scale. Each item response is measured on a Likert scale from 0-6, with total subscale scores reflecting the average of responses. Higher scores indicate higher group engagement.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  10. Therapeutic alliance

    Measured using the Working Alliance Inventory. Each item is measured on a 7-point Likert scale, with a range of 36-252 total. Higher scores indicates stronger alliance.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  11. Sleep

    Measured using the Insomnia Severity Index. The total score ranges from 0-28, with higher scores indicating worse insomnia.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  12. Pain Effects

    Measured using the Pain Effects Scale. The total score ranges from 6-30, with higher scores indicating greater impact of pain on behavior and mood.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  13. Fatigue

    Measured using the Modified Fatigue Impact Scale. The total score ranges from 0-84, with higher scores indicating a greater impact of fatigue.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

  14. Cognitive function

    Measured using the Symbol Digits Modalities Test. The total score ranges from 0-110, with higher scores indicating better cognitive functioning.

    Time frame: Measured at baseline, 8-week follow-up, and 3-month follow-up

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2025; primary completion for Dec 2026, 23 months later.

Of 852 non-industry interventional studies with no phase under Multiple Sclerosis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 43. This study's planned 23 months is close to that.

Counting every sponsor, half of 874 studies reached it within 21 months; a quarter within 9 and three quarters within 43.

How these figures are worked out, and which studies are left out of them.

Registered
May 8, 2024
First posted
May 16, 2024
StartEst.
Jan 1, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
May 31, 2027
Last update
Dec 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06415552
Lead sponsor
Robert Simpson
Responsible party
Robert Simpson (Investigator, Unity Health Toronto) — Sponsor-investigator
First posted
May 16, 2024
Start date
Jan 1, 2025 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Dec 6, 2024

Study contacts

Robert Simpson
Contact
Robert.Simpson@unityhealth.to
416-360-4000 ext. 40047

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion